33
Views
37
CrossRef citations to date
0
Altmetric
Review

Diffusion tensor imaging investigations in Alzheimer’s disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain

&
Pages 737-742 | Published online: 08 Aug 2008

Abstract

Diffusion tensor imaging (DTI) is a sophisticated MRI-based neuroimaging technique that enables in vivo quantification of differences in molecular diffusion at the cellular level. Owing to the highly directional architecture of white matter (WM), DTI is providing important clues of the structure and geometric organization of this neural compartment. Since DTI can detect changes even in the case of radiologically “normal” appearing WM, researchers are using the technique for the study of WM integrity at the initial stages of the most common neurodegenerative disorders. Along with a well characterized cortical pathology (neuritic plaques and intracellular neurofibrillary tangles), WM changes have been also demonstrated in Alzheimer’s disease (AD). However, these changes had been for years found nonliable in the onset and progress of AD, basically due to lack of incriminatory evidence. The use of novel tools such as DTI has enabled the anatomical distribution of WM microstructural damage in the prodromal stages of AD to be gauged and determined, granting a long-delayed protagonic role to WM in the natural history of this highly prevalent neurodegenerative condition.

The study of molecular diffusion by means of magnetic resonance imaging (MRI) has had a great impact in modern neuroscience. An MRI-based technique called diffusion weighted imaging (DWI) is perhaps one of the best examples of translational research from the basic sciences to the clinical arena – exploiting changes in cellular water diffusion properties and providing key information on the actual physiological state of brain tissue beyond the purely “anatomical” data. DWI enables a robust visualization of abnormalities within minutes of onset of cerebral ischemia (CitationMoseley et al 1990; CitationHossmann and Hoehn-Berlage 1995; CitationLutsep et al 1997; CitationYoneda et al 1999; CitationLansberg et al 2000), as well as white matter (WM) microstructural changes in several neurological conditions (CitationHigano et al 2001), including the dementia syndrome caused by Alzheimer’s disease (CitationHanyu et al 1998, Citation1999; CitationSandson et al 1999; CitationBozzao et al 2001; CitationKantarci et al 2001).

When physical barriers are absent, diffusion is isotropic, ie, equal in every direction. However, the intrinsic peculiarities of biological microenvironments work as constrictors of free water diffusion, obligating molecules to flow in a directional or anisotropic fashion. Despite its well deserved position as the standard imaging aid for the diagnosis and management of acute stroke (CitationNeumann-Haefelin et al 2000; CitationLansberg et al 2001), the information obtained from conventional DWI is limited to one dimension, based only on intensity values. To overcome this limitation, investigators engineered a sophisticated MRI modality called diffusion tensor imaging (DTI; CitationLe Bihan et al 2001). DTI quantifies molecular motion at the voxel level by means of a tensor, a mathematical concept that allows for complete tridimensional description of both the direction and the average magnitude of water diffusion (CitationBasser et al 1994a, Citationb; CitationBasser 1995).

The structure of WM consists mainly of highly organized, directionally insulated tracts formed by myelin-covered axons. Hence, diffusion anisotropy is more likely to be higher in WM than in other tissues, eg, gray matter (GM). DTI measures of WM anisotropy such as fractional anisotropy (FA; CitationBasser and Pierpaoli 1996) are currently regarded as markers of the integrity of neural axons (CitationBeaulieu 2002), positioning the technique as a reliable indicator of defects in geometric organization and fiber architecture in the context of disease. DTI has the advantage of examining the microstructural integrity of even radiologically “normal” appearing WM, enabling assessment of the status of WM at the initial stages of the most common neurodegenerative disorders.

Use of DTI to address the “dementia problem”

Alzheimer’s disease (AD) is pathologically defined by the presence of neuritic plaques, intracellular neurofibrillary tangles, and a greater loss of cortical neurons than in same-age, non-demented persons. Although they are most common in vascular dementia, independent white matter changes (WMC) have also been found in AD to a greater extent than in age-matched controls (CitationBrun and Englund 1986; CitationEnglund 1998; CitationKalaria 2000, Citation2002; CitationBronge et al 2002). However, the role of WMC in the pathogenesis, disease progression, and cognitive features of AD remained unsolved.

Mild cognitive impairment (MCI) is usually defined as a slight impairment in cognitive function – memory, in the case of amnestic MCI – but lacking enough criteria to be considered full dementia. MCI has become a common diagnosis in later life and is associated with a high risk of developing AD, with yearly conversion rates estimated at 10%–15% (CitationPetersen et al 2001). In vivo anatomical markers determined by quantitative MRI methods are being successfully used to differentiate patients with MCI and AD, respectively, from normal controls, and highly predictive indices of conversion (from MCI to AD) have been generated (CitationdeToledo-Morrell et al 2000, Citation2004; CitationKilliany et al 2000, Citation2002; CitationDickerson et al 2001).

Although mesial temporal cortical structures involved in memory function, such as the hippocampus and entorhinal cortex, have been traditionally under the scope of AD research (CitationJack et al 1992, Citation1997; CitationConvit et al 1997; CitationdeToledo-Morrell et al 1997, Citation2000, Citation2004; CitationBobinski et al 1999; CitationKilliany et al 2000, Citation2002; CitationXu et al 2000; CitationCallen et al 2001; CitationDickerson et al 2001; CitationDu et al 2001), DTI now is guiding scientists in their observations of the WM microstructural changes associated with aging and aging-related cognitive decline in the living brain. In AD in particular, the study of anisotropy changes has been focused on the prodromal and initial stages of the disease.

The localization of DTI-derived WM changes has been accomplished mostly by three methods: a) Selecting a region of interest (ROI), usually prescribed manually and from which anisotropy values are measured for statistical comparisons. b) Selecting a tract of interest from which the main eigenvector of diffusion, parallel to the major axis of the fiber bundle, is calculated. This method is called tractography and uses color codes and predetermined anatomical seeds (CitationConturo et al 1999; CitationPajevic and Pierpaoli 1999), to virtually dissect a complete WM tract from its origin to its termination in the brain (CitationVirta et al 1999; CitationPoupon et al 2000). c) More recently, fully automated whole-brain algorithms have been adopted to register individual anisotropy maps into standard space, and compute their changes by voxel-based statistics.

Using the ROI approach, several studies have looked at the WM of multiple brain lobes and some functionally relevant structures such as the superior longitudinal fasciculus, the cingulum bundle, and the corpus callosum. In summary, the majority of regional changes found in DTI indices of WM integrity are located posteriorly in the brains of MCI and AD subjects (CitationRose et al 2000; CitationBozzali et al 2002; CitationTakahashi et al 2002; CitationYoshiura 2002; CitationFellgiebel et al 2004, Citation2007; CitationHead et al 2004; CitationDuan et al 2006; CitationNaggara et al 2006; CitationHuang and Auchus 2007; CitationHuang et al 2007; CitationSydykova et al 2007). In contrast, effects of normal aging were found to be of greater magnitude in the WM of the frontal lobe and the anterior corpus callosum than in the WM of temporal, parietal, occipital, and posterior callosum regions (CitationHead et al 2004).

CitationMedina et al (2006) published an in vivo examination of normal-appearing WM microstructural integrity in individuals with MCI and mild AD using the whole brain approach for the first time, avoiding the biases of the a priori selection of ROIs. In this study, significant regional decreases in FA were found in the WM of the two patient groups, as opposed to age-matched healthy controls, in voxel-by-voxel comparisons. Interestingly, the anatomical pattern of FA changes was similar for both patient groups with greater posterior than anterior involvement. In a complementary experiment (CitationMedina et al 2005), the same methodology was used to detect significant voxel-wise FA reductions in a group of old normal controls (ONC) versus young normal controls (YNC). When these results were compared with the findings of the first experiment, the anterior/posterior distribution of voxel-wise anisotropy reductions was significantly different between the ONC vs YNC comparisons and the MCI and AD vs ONC comparisons, with a greater percentage of posterior WM integrity loss in the cognitively affected patients. These results further contribute to the body of evidence in favor of a more pronounced posterior WM damage in cognitively impaired elderly individuals.

What is DTI telling us?

The DTI-detected regional WM alterations in AD seem to parallel the pattern of changes followed by the GM in the disease process, that is, cortical abnormalities are greater in posterior brain regions relative to anterior regions at the early stages of AD (CitationArnold et al 1991; CitationBraak and Braak 1995). As the disease advances, the neurofibrillary pathology progresses from limbic to frontal structures, into high-order association cortices, and finally affects primary sensorimotor areas, which correlates with the clinical manifestations of AD. From post-mortem specimens to different imaging modalities, eg, MRI, PET, and SPECT, this typical sequence has been confirmed at different points of the disease (for a review, see CitationThompson et al 2007).

Fibers located deep in the posterior WM, such as the superior longitudinal fasciculus and the posterior cingulum bundle, are being consistently found to be affected in patients with AD and MCI, not only in ROI studies, but also in DTI-based tractography (CitationFellgiebel et al 2005; Xie et al 2005) and whole-brain DTI studies (CitationMedina et al 2006; CitationRose et al 2006; CitationZhang et al 2007). A strong body of evidence has supported the early involvement of the posterior cingulate (PC) in the progression of AD. Histologic, volumetric (CitationCallen et al 2001), and metabolic (CitationReiman et al 1996, Citation2001; CitationMinoshima et al 1997; CitationValla et al 2001) data have shown that the PC is not only involved early in AD, but it may also undergo changes even in asymptomatic genetically predisposed individuals (CitationReiman et al 2001). A plausible explanation for these phenomena has been proposed by Bartzokis (CitationBartzokis 2004; CitationBartzokis et al 2003, Citation2004). According to this model, as the brain development takes place, later myelinated regions (cortical association areas) have fewer oligodendrocytes supporting greater numbers of axons compared with earlier myelinated regions (primary sensorimotor regions). Oligodendrocytes in the cortical association areas have higher metabolic demands in order to maintain the widely distributed axons, making them more susceptible to pathological processes such as oxidative stress and accumulation of ferritin iron. These and other metabolic insults may lead to decreased WM integrity in association cortical regions. In general, the DTI findings of decreased WM integrity in later-myelinated regions at the onset of AD support this “reversed de-myelination” construct.

Cerebrovascular disease and WM dysfunction are inherently associated with vascular risk factors such as diabetes, myocardial infarction or hypertension. In addition to ischemic events, common in the elderly population, those factors seem to be also related to an increased risk of AD (CitationKalaria 2000, Citation2002; CitationUrresta et al 2003). Thus, vascular pathology may be an additive element to the deleterious effects of aging in more vulnerable, long cortico-cortical WM tracts.

DTI has been successfully applied to the study of diseases causing axonal damage (CitationUlug et al 1999), identifying reductions in anisotropy not only in macroscopic WM lesions but also at the microscopic level (CitationStieltjes et al 2001). The DTI renditions of changes in cerebral diffusion occurring in the WM of stroke patients have made possible the discrimination in vivo between primary (direct) and secondary (Wallerian) degeneration (CitationMakris et al 1997; CitationMukherjee et al 2000; CitationWerring et al 2000; CitationPierpaoli et al 2001). In the case of direct damage to the WM, as liquefactive necrosis takes place and the content of isotropic free water, ie cerebrospinal fluid, increases in the axon, severe reductions in FA are accompanied by an increase in mean diffusivity – otherwise known as trace D – as a result of a global increase in diffusivity in all directions. On the other hand, although Wallerian degeneration is also characterized by reduced FA and, albeit lesser, increases in mean diffusivity, there are differential changes in directional diffusivities: axial diffusivity (DA: diffusion parallel to the main axis of the tract) is reduced while radial diffusivity (DR: diffusion perpendicular to the main axis of the tract) remains high.

As mentioned in the previous section, there is plenty of pathoanatomical evidence of WMC in AD, thought to be the result of a constellation of pathologies such as WM rarefaction and axonal gliosis, probably related to ischemia, and an anterograde Wallerian degeneration that may follow the stereotypic pattern of AD cortical atrophy. Consequently, DTI directional diffusivities have been used to elucidate the extent of Wallerian degeneration in the normal-appearing WM of MCI and mild AD patients (Huang and Auchus 200; CitationHuang et al 2007). The most consistent findings of a pilot study using this approach (CitationHuang et al 2007) were seen in the temporal lobes: both MCI and AD groups showed significant reductions in FA, but the MCI group showed only a decrease in DA – probably reflecting an incipient axonal damage in a vulnerable target area – while the AD group showed decreases in DA and increases in DR, suggesting a more advance state of coexistent axonal destruction and demyelination that is coupled with the characteristic pattern of AD cortical loss.

DTI investigators are also looking for correlations between their regional estimations of WM integrity and cognitive function. Relationships have been sought between scores of a widely used diagnostic instrument in dementia studies, the Mini Mental State Examination (MMSE: CitationFolstein et al 1975), and WM mean diffusivity and anisotropy values, with findings of decreased cognitive status associated with decreased WM integrity in cerebral posterior regions of AD subjects (CitationRose et al 2000; CitationBozzali et al 2002; CitationYoshiura et al 2002; CitationDuan et al 2006). Further research including amnestic MCI populations and utilizing appropriate neuropsychological tests of declarative memory, has demonstrated significant correlations between declining performance in these tasks and decreases in posterior WM anisotropy, particularly in the posterior cingulum bundles (CitationFellgiebel et al 2005, Citation2007; CitationRose et al 2006). Moreover, CitationHuang et al (2007, see above) were able to delineate a neuroanatomical pattern of functional alterations in their cognitively impaired elderly subjects in such a way that changes in WM diffusion indices of the temporal lobes correlated with scores of episodic memory, WM diffusion changes in the frontal lobes correlated with scores of executive function, and WM diffusion changes in parietal lobes correlated with scores of visuospatial skills. This pattern might be indicative of the vulnerability of cortical cognitive systems to the deterioration of the WM pathways embedded beneath the disease-targeted gyri, and postulates disruptions in transcortical connectivity as an early contributor to the pathophysiology of dementia.

What’s coming next?

In pursuit of a deeper understanding of WMC in AD, investigators are narrowing their scope into brain areas that are difficult to access by conventional neuroimaging tools. The perforant path (PP), a parahippocampal WM bundle that originates from cells in the entorhinal cortex and provides the hippocampus with its major cortical input, has been elusive to the DTI community due to the technical constrains of the ROI approach, particularly in terms of partial volume effects. In an effort to surmount these difficulties, high resolution DTI protocols are being used in combination with high resolution anatomical MRI scans to obtain in vivo evidence of reductions in WM volume and FA in parahippocampal regions of patients with AD (CitationWang et al 2006). A similar bimodal ROI approach had comparable findings in a DTI study of the PP that included AD and MCI patients (CitationKalus et al 2006), and through the benefit of an optimized voxel-based method, CitationRose and colleagues (2006) were able to replicate parahippocampal WM changes when they examined a group of MCI patients. Taken together, these results suggest that a disruption in the flow of information to the hippocampus may exist since the beginnings of AD, giving WM dysfunction a refreshed protagonic role in the study of age-associated cognitive impairment.

Promising applications such as DTI-based tractography (DTT) or voxel-wise analyses are not free of limitations either. Apart from partial voluming effects, ubiquitous artifacts arise when a tract of interest is reconstructed through DTT, due to a problematic reproduction of the natural angulations of WM fibers. A recent advance in this topic is a provocative proposal by CitationYasmin et al (2008), in which a minimally operator-dependent optimized DTT technique, the “erosion” method, was used to detect neatly decreases in FA in the uncinate fasciculum of AD subjects. Problems in voxel-wise studies are related to the coregistration of individual DTI maps to standard templates and their segmentation via probability masks. Defining the proper criteria for smoothing and thresholding of the images for statistical purposes are additional issues. Laudable initiatives towards a careful alignment of DTI images and the use of sample-specific averages instead of exogenous templates have replicated the previously reported WM anisotropy changes occurring in posterior WM regions of AD subjects (CitationRose et al 2008).

A new technical development called tract-based spatial statistics (TBSS: CitationSmith et al 2006), which aimed to combine the strengths and to compensate for the weaknesses among the aforementioned methods, is being included in some of the commonly used open-source software tools for post-processing of DTI data. Instead of calculating the FA of a specific tract of interest, TBSS creates a “mean FA skeleton” from the very sample under investigation and later projects individual FA maps to this unique “skeleton-space”, avoiding alignment and smoothing issues and permitting voxel-wise statistical comparisons among groups. Although yet to be seen in AD, this kind of solution will surely help to provide more precise information about the WM compromise in the malfunction of the aging brain.

Current multi-center collaborative initiatives such a the National Alliance for Medical Imaging Computer (http://www.na-mic.org) or the Biomedical Informatic Research Network (http://www.nbirn.net) are trying to develop automated image calibration and analysis tools to facilitate the gathering of larger amounts of DTI data (among other imaging modalities), and to make that information available to the research community in public databases. These projects are seeking to enhance the applicability of the technique, ie, to develop biomarkers suitable for the monitoring of therapeutic efficacy in clinical trials, or to identify patients at risk and susceptible to benefit from early pharmacological interventions.

References

  • ArnoldSEHymanBTFloryJThe topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s diseaseCerebral Cortex19911103161822725
  • BartzokisGAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s diseaseNeurobiol Aging20042551814675724
  • BartzokisGCummingsJLSultzerDWhite matter structural integrity in healthy aging adults and patients with Alzheimer’s diseaseArch Neurol200360393812633151
  • BartzokisGSultzerDLuPHHeterogenous age related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s diseaseNeurobiol Aging2004258435115212838
  • BasserPJInferring microstructural features and the physiological state of tissues from diffusion-weighted imagesNMR Biomed19958333448739270
  • BasserPJMattielloJLeBihanDMR diffusion tensor spectroscopy and imagingBiophys J1994a66259678130344
  • BasserPJMatielloJLe BihanDEstimation of the effective self-diffusion tensor from the NMR spin echoJ Magn Reson B1994b103247548019776
  • BasserPJPierpaoliCMicrostructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRIJ Magn Reson B1996111209198661285
  • BeaulieuCThe basis of anisotropic water diffusion in the nervous system – a technical reviewNMR Biomed2002154355512489094
  • BobinskiMde LeonMJConvitAMRI of entorhinal cortex in mild Alzheimer’s diseaseLancet1999353384010023955
  • BozzaliMFaliniAFranceschiMWhite matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic tensor imagingJ Neurol Neurosurg Psychiatry200272742612023417
  • BozzaoAFlorisRBavieraMEDiffusion and perfusion MR imaging in cases of Alzheimer’s disease: correlations with cortical atrophy and lesion loadAJNR Am J Neuroradiol2001221030611415893
  • BraakHBraakEStaging of Alzheimer’s disease-related neurofibrillary changesNeurobiol Aging19951627187566337
  • BrongeLBogdanovicNWahlundLOPostmortem MRI and histopathology of white matter changes in Alzheimer brainsDement Geriatr Cogn Disord2002132051212006730
  • BrunAEnglundEA white matter disorder in dementia of the Alzheimer type: a pathoanatomical studyAnn Neurol198619253623963770
  • CallenDJABlackSEGaoFBeyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in ADNeurology20015716697411706109
  • ConturoTELoriNFCullTSTracking neuronal fiber pathways in the living human brainProc Natl Acad Sci USA19999610422710468624
  • ConvitAde LeonMJTarshishCSpecific hippocampal volume reductions in individuals at risk for Alzheimer’s diseaseNeurobiol Aging199718131189258889
  • deToledo-MorrellLGoncharovaIDickersonBFrom healthy aging to early Alzheimer’s disease. In vivo detection of entorhinal cortex atrophyAnn NY Acad Sci20009112405310911878
  • deToledo-MorrellLStoubTRBulgakovaMMRI-derived entorhinal volume is a good predictor of conversion from MCI to ADNeurobiol Aging200425119720315312965
  • deToledo-MorrellLSullivanMPMorrellFAlzheimer’s disease: In vivo detection of differential vulnerability of brain regionsNeurobiol Aging19971846389390771
  • DickersonBCGoncharovaISullivanMPMRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s diseaseNeurobiol Aging2001227475411705634
  • DuATSchuffNAmendDMagnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry200171441711561025
  • DuanJHWangHQXuJWhite matter damage of patients with Alzheimer’s disease correlated with the decreased cognitive functionSurg Radiol Anat200628150616614789
  • EnglundENeuropathology of white matter changes in Alzheimer’s disease and vascular dementiaDement Geriatr Cogn Disord19989Suppl 16129716238
  • FellgiebelAMüllerMJWillePColor-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairmentNeurobiol Aging2005261193815917103
  • FellgiebelASchermulyIGerhardAFunctional relevant loss of long association fibre tracts integrity in early Alzheimer’s diseaseNeuropsychologia2007 Dec 23 Epub ahead of print
  • FellgiebelAWillePMüllerMJUltrastructural hippocampal and white matter alterations in Mild Cognitive Impairment: a diffusion tensor imaging studyDement Geriatr Cogn Disord200418101815087585
  • FolsteinMFFolsteinSEMcHughPRMini-Mental State. A Practical method for grading the mental status of patients for the clinicianJ Psychiatric Res19751218992
  • HanyuHAsanoTSakuraiHDiffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s diseaseJ Neurol Sci1999167374410500260
  • HanyuHSakuraiHIwamotoTDiffusion-weigthed MR imaging of the hippocampus and temporal white matter in Alzheimer’s DiseaseJ Neurol Sci19981561952009588857
  • HeadDBucknerRLShimonyJSDifferential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: Evidence from diffusion tensor imagingCereb Cortex2004144102315028645
  • HiganoSZhongJShrierDADiffusion anisotropy of the internal capsule and the corona radiata in association with stroke and tumors as measured by diffusion-weighted MR imagingAJNR Am J Neuroradiol2001224566311237966
  • HossmannKAHoehn-BerlageMDiffusion and perfusion MR imaging of cerebral isquemiaCerebrovasc Brain Metab Rev199571872178519603
  • HuangJAuchusAPDiffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer’s diseaseAnn NY Acad Sci200710972596417413027
  • HuangJFriedlandRPAuchusAPDiffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobeAJNR Am J Neuroradiol2007281943817905894
  • JackCRPetersenRCO’BrienPCMR-based hippocampal volumetry in the diagnosis of Alzheimer’s diseaseNeurology19924218381734300
  • JackCRPetersenRCXuYCMedial temporal atrophy on MRI in normal aging and very mild Alzheimer’s diseaseNeurology199749786949305341
  • KalariaRNThe role of cerebral ischemia in Alzheimer’s diseaseNeurobiol Aging2000213213010867217
  • KalariaRNSmall vessel disease and Alzheimer’s dementia: Pathological considerationsCerebrovasc Dis200213Suppl 2485211901243
  • KalusPSlotboomJGallinatJExamining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementiaNeuroimage2006307132016337815
  • KantarciKJackCRXuYCMild cognitive impairment and Alzheimer’s disease: Regional diffusivity of waterRadiology2001219101711274543
  • KillianyRJGomez-IslaTMossMUse of structural magnetic resonance imaging to predict who will get Alzheimer’s diseaseAnn Neurol200047430910762153
  • KillianyRJHymanBTGomez-IslaTMRI measures of entorhinal cortex vs hippocampus in preclinical ADNeurology20025811889611971085
  • LansbergMGAlbersGWBeaulieuCComparison of diffusion-weighted MRI and CT in acute strokeNeurology20005415576110762493
  • LansbergMGO’BrienMWTongDCEvolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imagingArch Neurol200158613711295992
  • Le BihanDManginJFPouponDiffusion tensor imaging: concepts and applicationsJ Magn Reson Imaging2001135344611276097
  • LutsepHLAlbersGWDeCrespignyAClinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic strokeAnn Neurol199741574809153518
  • MedinaDAStebbinsGTdeToledo-MorrellLDTI detects dissociated patterns on regional distribution of white matter changes in the elderly2005Washington, DCSociety for Neuroscience Program No. 542.13. 2005 Abstract Viewer/Itinerary Planner online
  • MedinaDdeToledo-MorrellLUrrestaFWhite matter changes in mild coginitve impairment and AD: a difusion tensor imaging studyNeurobiol Aging2006276637216005548
  • MinoshimaSGiordaniBBerentSMetabolic reduction in the posterior cingulate cortex in very early Alzheimer’s diseaseAnn Neurol19974285949225689
  • MakrisNWorthAJSorensonAGMorphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imagingAnn Neurol199742951629403488
  • MoseleyMECohenYMintorovitchJEarly detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopyMagn Reson Med199014330462345513
  • MukherjeePBahnMMMcKinstryRCDifferences between gray matter and white matter diffusion in stroke: Diffusion-tensor MR imaging in 12 patientsNeuroradiology200021521120
  • NaggaraOOppenheimCRieuDDiffusion tensor imaging in early Alzheimer’s diseasePsychiatry Res2006146243916520023
  • Neumann-HaefelinTMoseleyMEAlbersGWNew magnetic resonance imaging methods for cerebrovasclular disease: emerging clinical applicationsAnn Neurol2000475597010805325
  • PajevicSPierpaoliCColor schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brainMagn Reson Med19994252640 erratum in Magn Reson Med, 2000 43(6):92110467297
  • PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairmentArch Neurol20015819859211735772
  • PierpaoliCBarnettAPajevicSWater diffusion changes in wallerian degeneration and their dependence on white matter architectureNeuroimage20011311748511352623
  • PouponCClarkCAFrouinVRegularization of diffusion-based direction maps for the tracking of brain white matter fasciclesNeuroimage2000121849510913324
  • ReimanEMCaselliRJChenKDeclining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer’s diseaseProc Natl Acad Sci USA2001983349
  • ReimanEMCaselliRJYunLSPreclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein EN Engl J Med199633475288592548
  • RoseSEChenFChalkJBLoss of connectivity in Alzheimer’s disease: an evaluation of white matter tract integrity with color coded MR diffusion tensor imagingJ Neurol Neurosurg Psychiatry2000695283010990518
  • RoseSEJankeALChalkJBGray and white matter changes in Alzheimer’s disease: a diffusion tensor imaging studyJ Magn Reson Imaging20082720618050329
  • RoseSEMcMahonKLJankeALMRI diffusion indices and neuropsychological performance in amnestic mild cognitive impairmentJ Neurol Neurosurg Psychatry20067711228
  • SandsonTAFelicianOEdelmanRRDiffusion-weighted magnetic resonance imaging in Alzheimer’s diseaseDement Geriatr Cogn Disord1999101667110026392
  • SmithSMJenkinsonMJohansen-BergHTract-based spatial statistics: voxelwise analysis of multi-subject diffusion dataNeuroimage200631148750516624579
  • StieltjesBKaufmannWEvan ZijlPCDiffusion tensor imaging and axonal tracking in the human brainstemNeuroimage2001147233511506544
  • SydykovaDStahlRDietrichOFiber connections between the cerebral cortex and the corpus callosum in Alzheimer’s disease: a diffusion tensor imaging and voxel-based morphometry studyCereb Cortex20071722768217164468
  • TakahashiSYonezawaHTakahashiJSelective reduction of diffusion anisotropy in white matter of Alzheimer’s disease brains measured by 3.0 Tesla magnetic resonance imagingNeurosci Lett200233245812377381
  • ThompsonPMHayashiKMDuttonRATracking Alzheimer’s diseaseAnn NY Acad Sci2007109718321417413023
  • UlugAMooreDFBojkoASClinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damageAJNR Am J Neuroradiol1999201044810445441
  • UrrestaFMedinaDAGaviriaMDiffusion MRI studies in vascular cognitive impairment and dementiaRev Bras Psichiatr20032518891
  • VallaJBerndtJDGonzalez-LimaFEnergy hypometabolism in posterior cingulate cortex of Alzheimer’s patients: superficial laminar cytochrome oxidase associated with disease durationJ Neurosci20011349233011425920
  • VirtaABarnettAPierpaoliCVisualizing and characterizing white matter fiber structure and architecture in the human pyramidal tract using diffusion MRIMag Reson Imaging199917112133
  • WangCMedinaDStebbinsGChanges in the microstructural integrity of parahippocampal white-matter tracts in Alzheimer’s disease2006 Neuroscience Meeting Planner2006Atlanta, GASociety for Neuroscience online
  • WerringDJToosyATClarkCADiffusion tensor imaging can detect and quantify corticospinal tract degeneration after strokeJ Neurol Neurosurg Psychiatry2000692697210896709
  • XuYJackCRO’BrienPCUsefulness of MRI measures of entorhinal cortex versus hippocampus in ADNeurology2000541760710802781
  • YasminHNakataYAokiSDiffusion abnormalities of the uncinate fasciculus in Alzheimer’s disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tractNeuroradiology2008504293918246334
  • YonedaYTokuiKHaniharaTDiffusion-weighted magnetic resonance imaging: detection of isquemic injury 39 minutes after onset in a stroke patientAnn Neurol199945794710360773
  • YoshiuraTMiharaFOgomoriKDiffusion tensor in posterior cingulate gyrus: correlation with cognitive decline in Alzheimer’s diseaseNeuroreport200213229930212488815
  • ZhangYSchuffNJahngGHDiffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer diseaseNeurology200768131917200485